Roche Blood Screening Test Helps CDC Show Zika Infections Increasing in Puerto Rico | GenomeWeb

NEW YORK (GenomeWeb) – The US Centers for Disease Control and Prevention has published data from Puerto Rico regarding the use of an investigational PCR-based blood-screening Zika test from Roche to demonstrate that infection rates are increasing.

During a telebriefing this morning to provide an update on screening of blood donations for Zika virus, Matthew Kuehnert, director of the agency's office of blood, organ, and other tissue safety, described the Roche Cobas test as "extremely accurate."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.